November 8, 2025 · Form 4 insider transaction
Bruehlman Ronald E bought 21,691 shares of GoodRx Holdings, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).; Each restricted stock unit represents a contingent right to receive one share of Class A common stock.